Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 340, Issue 6, pp 689–695 | Cite as

Effects of adenosine analogues on contractile response and CAMP content in guinea-pig isolated ventricular myocytes

  • Joachim Neumann
  • Wilhelm Schmitz
  • Hasso Scholz
  • Birgitt Stein


In the present study the effects of adenosine analogues were investigated on cAMP content and contractile response in guinea-pig ventricular myocytes. The adenosine analogues (−)-N6-phenylisopropyladenosine (R-PIA), 5′-N-ethylcarboxamideadenosine (NECA) and (+)-N6-phenyl-isopropyladenosine (S-PIA) in the presence of 0.01 μmol/l isoprenaline reduced contractile response concentration-dependently. R-PIA and NECA were about equipotent (IC25: 0.01 μmol/l and 0.039 μmol/l respectively), while S-PIA was less potent (IC25: 0.6 μmol/l). Isoprenaline stimulated cAMP content was reduced by R-PIA (IC25: 0.004 μmol/l) and with lower potency by S-PIA (IC25: 0.15 μmol/l) but the extent of reduction of cAMP by R-PIA and S-PIA (to 55% and 64% respectively) was less than the reduction of contractile response (to 26% and 55% respectively). This suggests that the effects of R- and S-PIA on contractile response are only in part due to a reduction in cAMP content. In addition, NECA did not decrease cAMP content but decreased contractile response to the same extent as R-PIA. Similar results were obtained in the presence of the phosphodiesterase inhibitor Ro 20-1724. Time course studies revealed that the effects of R-PIA (1 μmol/l) on cAMP content and contractile response coincided reaching steady state after 5 min and remained stable thereafter. The effects of NECA (1 µmol/l) on contractility also reached steady state within 5 min, whereas it did not change cAMP content. It is concluded that the reduction of contractility by adenosine analogues in the presence of isoprenaline can only in part be explained by a reduction of cAMP content. It is suggested that a cAMP-independent effect, possibly an activation of phosphatases, might be involved additionally.

Key words

Adenosine analogues cAMP Isolated ventricular myocytes Contractile response Guinea-pig hearts Isoprenaline Phosphodiesterase inhibitor 








Ro 20-1724



Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ahmad Z, Green FJ, Watanabe AM (1987) Autonomic regulation of type 1 phosphatase in cardiac muscle. Circulation 76 (Suppl IV):342Google Scholar
  2. Anand-Srivastava MB, Cantin M (1983) Regulation of adenylate cyclase in cultured cardiocytes from neonatal rats by adenosine and other agonists. Arch Biochem Biophys 223:468–476Google Scholar
  3. Anand-Srivastava MB (1985) Regulation of adenylate cyclase by adenosine and other agonists in rat myocardial sarcolemma. Arch Biochem Biophys 243:439–446Google Scholar
  4. Anversa P, Levicky V, Beghi C, McDonald SL, Kikkawa Y (1983) Morphometry of exercise-induced right ventricular hypertrophy in the rat. Circ Res 52:57–64Google Scholar
  5. Bellardinelli L, Isenberg G (1983) Action of adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ Res 53:287–297Google Scholar
  6. Böhm M, Brückner R, Hackbarth I, Haubitz B, Linhart R, Meyer W, Schmidt B, Schmitz W, Scholz H (1984) Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect. J Pharmacol Exp Ther 230:483–492Google Scholar
  7. Böhm M, Brückner R, Hackbarth I, Meyer W, Nose M, Schmitz W, Scholz H, Starbatty J (1985) Evidence for adenosine receptor-mediated isoprenaline-antagonistic effects of the adenosine analogs PIA and NECA on force of contraction in guinea-pig atrial and ventricular cardiac preparations. Naunyn-Schmiedeberg's Arch Pharmacol 331:131–139Google Scholar
  8. Böhm M, Brückner R, Neumann J, Schmitz W, Scholz H, Starbatty J (1986) Role of guanine nucleotide-binding protein in the regulation by adenosine of cardiac potassium conductance and force of contraction. Evaluation with pertussis toxin. Naunyn-Schmiedeberg's Arch Pharmacol 332:403–405Google Scholar
  9. Bradford MM (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254Google Scholar
  10. Brückner R, Fenner A, Meyer W, Nobis T-M, Schmitz W, Scholz H (1985) Cardiac effects of adenosine and adenosine analogs in guinea-pig atrial and ventricular preparations: evidence against a role of cyclic AMP and cyclic GMP. J Pharmacol Exp Ther 234:766–773Google Scholar
  11. Burstone MS (1962) Enzyme histochemistry and its application in the study of neoplasm. Academic Press, New York, LondonGoogle Scholar
  12. Capogrossi MC, Kort AA, Spurgeon HA, Lakatta EG (1986) Single adult rabbit and rat cardiac myocytes retain the Ca2+- and species-dependent systolic and diastolic contractile properties of intact muscle. J Gen Physiol 88:589–613Google Scholar
  13. Des Rosier C, Nees S (1987) Functional evidence for the presence of adenosine A2-receptors in cultured coronary endothelial cells. Naunyn-Schmiedeberg's Arch Pharmacol 336:94–98Google Scholar
  14. Dobson JG Jr (1978) Reduction by adenosine of the isoproterenol-induced increase in cyclic adenosine 3′,5′-monophosphate formation and glycogen phosphorylase activity in rat heart muscle. Circ Res 43:785–792Google Scholar
  15. Dobson JG Jr (1983) Mechanism of adenosine inhibition of catecholamine-induced responses in heart. Circ Res 52:151–160Google Scholar
  16. Dobson JG Jr, Fenton RA (1983) Antiadrenergic effects of adenosine in the heart. In: Berne RM, Rall TW, Rubio R (eds) Regulatory function of adenosine. Martinus-Nijhoff, Boston, pp 363–376Google Scholar
  17. Garcia-Sainz JA, Torner ML (1985) Rat fat-cells have three types of adenosine receptors 8 (Rs Ri and P). Differential effects of pertussis toxin. Biochem J 232:439–443Google Scholar
  18. Harding SE, Vescovo G, Kirby M, Jones SM, Gurden J, Poole-Wilson PA (1988) Contractile response of isolated adult rat and rabbit cardiac myocytes to isoproterenol and calcium. J Mol Cell Cardiolog 20:635–647Google Scholar
  19. Hazeki O, Ui M (1980) Beta1- and beta2-adrenergic receptors reponsible for cyclic AMP accumulation in isolated heart and lung cells. Mol Pharmacol 17:8–13Google Scholar
  20. Henrich M, Piper HM, Schrader J (1987) Evidence for adenylate cyclase-coupled A1-adenosine receptors on ventricular cardiomyocytes from adult rat and dog heart. Life Sci 41: 2381–2388Google Scholar
  21. Huang M, Drummond GI (1978) Interaction between adenosine and catecholamines on cyclic AMP accumulation in guinea-pig ventricular myocardium. Biochem Pharmacol 27:187–191Google Scholar
  22. Isenberg G, Klöckner U (1982) Calcium tolerant ventricular myocytes prepared by preincubation in a “KB medium”. Pflügers Arch 395:6–18Google Scholar
  23. Isenberg G, Cerbai E, Klöckner U (1987) Ionic channels and adenosine in isolated heart cells. In: Gerlach E, Becker BF (eds) Topics and perspectives in adenosine research. Springer, Berlin Heidelberg New York Tokyo, pp 323–335Google Scholar
  24. LaMonica DA, Frohloff N, Dobson JG Jr (1985) Adenosine inhibition of catecholamine-stimulated cardiac membrane adenylate cyclase. Am J Physiol 248:H 737-H 744Google Scholar
  25. Leung E, Kwatra MM, Hosey MM, Green RD (1988) Characterization of cardiac A1 adenosine receptors by ligand binding and photoaffinity labeling. J Pharmacol Exp Ther 244:1150–1156Google Scholar
  26. Linden J, Hollen CE, Patel A (1985) The mechanism by which adenosine and cholinergic agents reduce contractility in rat myocardium. Correlation with cyclic adenosine monophosphate and receptor densities. Circ Res 56:728–735Google Scholar
  27. Lohse MJ, Ukena D, Schwabe U (1985) Demonstration of Ri type adenosine receptors in bovine myocardium by radioligand binding. Naunyn-Schmiedeberg's Arch Pharmacol 328:310–316Google Scholar
  28. Londos C, Cooper DMF, Wolff J (1980) Subclasses of external adenosine receptors. Proc Natl Acad Sci (USA) 77:2551–2554Google Scholar
  29. Martens D, Lohse MJ, Rauch B, Schwabe U (1987) Pharmacological characterization of A1 adenosine receptors in isolated rat ventricular myocytes. Naunyn-Schmiedeberg's Arch Pharmacol 336:342–348Google Scholar
  30. Neels HM, Van Sande ME, Scharpe SL (1983) Sensitive colorimetric assay for angiotensin converting enzyme in serum. Clin Chem 29:1399–1403Google Scholar
  31. Neumann J, Schmitz W, Stein B (1988) Effects of (−)-N6-phenyliso-propyladenosine on contractile response and CAMP content in electrically stimulated ventricular myocytes. Naunyn-Schmiedeberg's Arch Pharmacol 337 (Suppl):R62Google Scholar
  32. Ondetti M, Cushman D (1982) Enzymes of the renin-angiotensin system and their inhibitors. Ann Rev Biochem 51:515–529Google Scholar
  33. Piper HM, Probst I, Schwartz P, Hütter FJ, Spieckermann PG (1982) Culturing of calcium stable adult cardiac myocytes. J Mol Cell Cardiol 14:397–412Google Scholar
  34. Reithmann C, Thomschke A, Werdan K (1987) The role of endogenous noradrenaline in beta-blocker withdrawal phenomenon-studies with cultured heart cells. Klin Wochenschr 65:308–316Google Scholar
  35. Schmitz W, Böhm M, Brückner R, Burmann H, Meyer W, Neumann J, Nose M, Scholz H (1985) Relationship between the effects of cAMP-increasing agents and adenosine in the mammalian heart. In: Stefanovich V, Rudolphi K, Schubert P (eds) Adenosine: Receptors and modulation of cell function. IRL Press, Oxford, pp 295–305Google Scholar
  36. Schmitz W, Heller T, Köcher M, Neumann J, Scholz H, Scholz J, Stemmildt V, Störtzel K (1988) On the mechanism of action of adenosine on myocardial contractility. In: Paton DM (ed) Adenosine and adenine nucleotides: Physiology and pharmacology. Taylor and Francis, London Philadelphia New York, pp 167–176Google Scholar
  37. Scholz H, Böhm H, Brückner R, Neumann J, Schmitz W (1987) Mechanism of the “antiadrenergic” effects of adenosine on myocardial force of contraction. In: Gerlach E, Becker BF (eds) Topics and perspectives in adenosine research. Springer, Berlin Heidelberg New York Tokyo, pp 369–382Google Scholar
  38. Schrader J, Baumann G, Gerlach E (1977) Adenosine as inhibitor of myocardial effects of catecholamines. Pflügers Arch 372:29–35Google Scholar
  39. Schütz W, Freissmuth M, Hausleithner V, Tuisl E (1986) Cardiac sarcolemmal purity is essential for the verification of adenylate cyclase inhibition via A1-adenosine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 333:156–162Google Scholar
  40. Stein B, Neumann J, Schmitz W, Scholz H (1988) Evidence for cAMP independent effects of adenosine derivatives in ventricular myocytes. Naunyn-Schmiedeberg's Arch Pharmacol 338 (Suppl):R39Google Scholar
  41. Struck CJ, Ahnert G, Glossmann H, Schaeg W (1977) Solid phase radioimmunoassay for cyclic AMP using staphylococcal protein as antibody adsorbent. Naunyn-Schmiedeberg's Arch Pharmacol 298:67–73Google Scholar
  42. Van Calker D, Muller N, Hamprecht B (1979) Adenosine regulates by two different types of receptors the accumulation of cyclic AMP in cultured brain cells. J Neurochem 33:999–1005Google Scholar
  43. West GA, Isenberg G, Belardinelli L (1986) Antagonism of forskolin effects by adenosine in isolated hearts and ventricular myocytes. Am J Physiol 250:H 769-H 777Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • Joachim Neumann
    • 1
  • Wilhelm Schmitz
    • 1
  • Hasso Scholz
    • 1
  • Birgitt Stein
    • 1
  1. 1.Abteilung Allgemeine Pharmakologie, Universitäts-Krankenhaus EppendorfUniversität HamburgHamburg 20Germany

Personalised recommendations